The authors interpret this as suggestive that adipocyte-derived KLB has no effect on obesity-mediated FGF21 resistance, but it could also be that adipocyte-KLB is not required for obesity-associated FGF21 increases. The gene discussed is FGF21; the disease is obesity disorder.